Related Experiment Video
Updated: Jun 7, 2026
07:40
Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
Published on: January 12, 2022
Two mouse models for recoverin-associated autoimmune retinopathy
1Department of Ophthalmology and Visual Sciences Kellogg Eye Center, University of Michigan, Ann Arbor, MI, 48105, USA.
Molecular Vision
|October 30, 2010
Summary
Two mouse models of autoimmune retinopathy (AIR) targeting recoverin were developed. Both models showed retinal pathology, including inflammation and neuronal degeneration, validating their use for studying AIR.
Area of Science:
- Ophthalmology
- Immunology
- Neuroscience
Background:
- Recoverin is a key antigen in autoimmune retinopathy (AIR).
- Developing reliable mouse models is crucial for understanding AIR pathogenesis.
- Anti-recoverin antibodies are implicated in retinal damage.
Purpose of the Study:
- To establish and characterize two distinct mouse models of AIR.
- To investigate the pathological effects of anti-recoverin antibodies in the retina.
- To provide tools for studying AIR and testing potential treatments.
Main Methods:
- Immunization of B6.MRL-Fal(lpr)/J mice with recombinant recoverin.
- Injection of hybridoma cells producing anti-recoverin monoclonal antibodies into Balb/cJ mice.
- Analysis of antibody levels, retinal function (ERG), histology, and cellular infiltration.
Main Results:
- Both models achieved high anti-recoverin antibody levels and exhibited reduced ERG responses.
- Retinal histology revealed inner nuclear layer swelling (LPR mice) and photoreceptor/outer nuclear layer swelling (Balb/cJ mice).
- Increased reactive gliosis, bipolar cell loss, complement deposition, and immune cell infiltration were observed in both models.
Conclusions:
- The developed mouse models exhibit similar retinal pathologies, confirming recoverin antibody-induced events.
- These models are valuable for investigating AIR pathophysiology and evaluating therapeutic strategies.
- The models allow for the study of specific autoantibodies' roles in retinal damage and protein interactions.
